FDA device listing
BD Respiratory Viral Panel for BD MAX™ System,BD Respiratory Viral Panel-SCV2 for BD MAX™ System
FDA device listing 1351006948 · Becton Dickinson and Company
Key facts
| Proprietary names | BD Respiratory Viral Panel for BD MAX™ System,BD Respiratory Viral Panel-SCV2 for BD MAX™ System |
|---|---|
| Owner/operator | Becton Dickinson and Company |
| Owner/operator number | 9922032 |
| Premarket submissions | K230956 |
| Product codes | QOF, QQX |
| Device names | QOF - Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents, QQX - Respiratory Specimen Nucleic Acid Sars-Cov-2 Test |
| Device class | Class II |
| Classification regulations (21 CFR) | 866.3981 |
| Review panels | Microbiology |
| Registered establishments | BECTON, DICKINSON & CO., GeneOhm Sciences Canada, ULC. |
| Establishment registrations | 1119779, 3007420875 |
| FEI numbers | 1119779, 3007420875 |
| Establishment operations | Complaint File Establishment, Manufacturer, Specification Developer |
| Registration valid through | 2026 |
At a glance
- 1–9 Registered establishments listing this device
- 1–9 UDI devices (GUDID) under the same submission
- 1–9 Device listings citing the same submission
- Yes Premarket submission listed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA device listings
Establishments that make or process devices for the U.S. market must list each device with the FDA. A listing records the device's proprietary names, product codes and premarket submission, and every registered establishment that handles it.
Source: U.S. Food and Drug Administration (FDA), Establishment Registration and Device Listing database